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doi:10.1016/j.ejvs.2009.11.011Abstract Background: Filter-protected transcervical carotid artery stenting (CAS) has been
suggested to reduce the intraoperative cerebral embolisation observed during transfemoral
CAS. We therefore evaluated clinical outcome and incidence of ischaemic lesions at diffu-
sion-weighted magnetic resonance imaging (DW-MRI) after transcervical and transfemoral
CAS.
Methods: From March 2007 to May 2009, we performed filter-protected CAS in 135 patients
with symptomatic (30%) or asymptomatic (70%) carotid stenosis above 70% and below 95%. In
44 patients with risky femoral access or unfavourable aortic arch anatomy, access to
common carotid artery was achieved by a small cervical incision. In another 91 procedures
we used a classic percutaneous femoral access. Preoperative and postoperative DW-MRI
scans were obtained after 111 procedures (82%) e 35 transcervical and 76 transfemoral.
Results: The incidence of clinical events (transient ischaemic attack (TIA) and stroke) was
2.3% after transcervical CAS and 19.8% after transfemoral CAS (P < 0.01), without any
deaths. DW-MRI disclosed new ischaemic lesions in five patients (5/35, 14.3%) after transcer-
vical CAS and in 28 patients (28/76, 36.8%) after transfemoral CAS (PZ 0.015). All ischaemic
lesions depicted after transcervical procedures were ipsilateral to the treated artery.
Conclusions: Transcervical filter-protected CAS, compared with classic percutaneous proce-
dures, seems to reduce clinical events and DW-MRI ischaemic damage and may be useful in
selected patients.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.nt of Vascular Surgery, Ospedale Sant’Andre, Via di Grottarossa 1035, 00189 Rome, Italy. Tel.: þ39 06
tiscali.it (G. Palombo).
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Table 1 Baseline characteristics of the 135 patients
included in the study.
Characteristic Transcervical
CAS
Transfemoral
CAS
P
N patients 44 91
Mean age in years (range) 72.1 (57e82) 74.1 (59e88) NS
Age 80 years (%) 7 (15.9) 17 (18.7) NS
Sex
Men (%) 33 (75) 59 (65) NS
Women (%) 11 (25) 32 (35) NS
Carotid stenosis
70e80% (%) 24 (55) 35 (38) NS
81e95% (%) 20 (45) 56 (62) NS
Type of carotid plaque
Type 1e2 (%) 11 (25) 23 (25) NS
Type 3e5 (%) 33 (75) 68 (75) NS
Contralateral carotid stenosis
<50% (%) 26 (59) 61 (67) NS
50e99% (%) 16 (36) 27 (30) NS
Occlusion (%) 2 (5) 3 (3) NS
Clinical presentation
Symptomatic (%) 14 (32) 27 (30) NS
Asymptomatic (%) 30 (68) 64 (70) NS
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Transfemoral carotid artery stenting (CAS) has emerged in
these past years as a possible alternative to carotid
endarterectomy for treating patients with carotid
stenosis.1 Cerebral protection systems, mainly distal filters,
are currently used and seem able to reduce stroke and
death rates to values almost overlapping those observed
after surgery.2,3
Silent cerebral embolisation during CAS nevertheless
remains an open problem insofar as numerous studies using
diffusion-weighted magnetic resonance imaging (DW-MRI)
document a high incidence of new asymptomatic post-
procedural cerebral ischaemic lesions.4,5 The report of
ischaemic lesions in cerebral territories not directly
involved by the carotid procedure6 or after a merely diag-
nostic angiographic study of the supra-aortic trunks7
suggests that a non-negligible part of the procedural
embolic load could be linked to aortic arch instrumentation
inherent in transfemoral procedures. A higher incidence of
adverse clinical events8 and postoperative DW-MRI ischae-
mic lesions9 was indeed reported in octogenarians, known
to have increased prevalence of aortic arch atherosclerosis
and complex anatomy.10 Moreover, as transfemoral access
for CAS may not be feasible in patients with severe and
bilateral aorto-iliac occlusive disease, common carotid
cannulation may also be impossible in patients with
tortuous supra-aortic trunks or unfavourable aortic arch. In
a recent article evaluating the impact of tortuosities on
transfemoral CAS, a technical failure related to aortic arch
or common carotid artery tortuosities was reported in 9% of
the procedures, showing that this eventuality should not be
underestimated.11
To reduce the inherent embolic load and to overcome
possible difficulties linked to femoral access, some have
proposed to perform filter-protected CAS through
a cervical access, either percutaneous or surgical.12e14
Even if reported clinical outcomes were satisfactory, no
DW-MRI data or comparison with transfemoral filter-pro-
tected CAS was provided. Hence, we undertook this non-
randomised observational study to compare transcervical
and transfemoral filter-protected CAS in terms of clinical
outcome and procedural embolisation rate, evaluated by
DW-MRI.
Materials and methods
From March 2007 to May 2009, we performed filter-pro-
tected carotid stenting in 135 patients. In 44 of these
patients the procedure was done through a small cervical
cut-down while in the other 91 patients we used a classic
percutaneous transfemoral approach. Baseline character-
istics of patients included in this study are summarised in
Table 1. The transcervical approach was always preferred
in cases of difficult or risky femoral approaches (severe and
bilateral aorto-iliac occlusive disease, large abdominal
aortic aneurysm (>5 cm) or presence of an aortobifemoral
prosthesis). In presence of a complex anatomy of aortic
arch or supra-aortic trunks (type III arch, bovine arch,
common carotid artery (CCA) coiling or kinking), a cervical
access was chosen according to the operating surgeon’sexperience in endovascular procedures: while the vascular
surgeon with a broad experience always chose the femoral
route, another two vascular surgeons at the beginning of
their experience in carotid stenting preferred cervical
access. Femoral access and anatomic features of patients
undergoing transcervical and transfemoral CAS are listed in
Table 2. Contraindications to cervical access were circum-
ferential and diffused atheromatous disease of the CCA or
an anatomically low carotid bifurcation (less than 5 cm
above the clavicle). No patients in these series were
excluded for these reasons. Carotid stenting was indicated
in presence of a symptomatic or asymptomatic stenosis of
the internal carotid artery (ICA)  70%. To avoid a risky
crossing or an unprotected predilation of the lesion,
patients with endoluminal thrombus or tight stenosis
(>95%) were excluded. Another exclusion criteria was the
presence of an excessive tortuosity of the distal ICA
precluding proper filter deployment. Patients excluded
from stenting were referred to surgery. Written informed
consent was obtained from all patients, and the procedures
were approved by the hospital ethics committee.
Except for one patient who had a restenosis from
a previous endarterectomy, all patients had primary
atherosclerotic lesions of the ICA, as documented on
ultrasound. The degree of carotid stenosis was evaluated
according to velocimetric and morphologic criteria. Plaque
structure was assessed by B-mode ultrasonography and
defined according to the Geroulakos15 criteria: type 1:
uniformly echolucent; type 2: predominantly echolucent;
type 3: predominantly echogenic; type 4: uniformly echo-
genic; and type 5: not classifiable owing to heavy calcifi-
cation producing acoustic shadow. All patients underwent
preoperative magnetic resonance angiography (MRA) or
computed tomographic angiography (CTA) to study the
aortic arch and the supra-aortic vessels.
Table 2 Femoral access and anatomic issues in patients undergoing transcervical CAS and transfemoral CAS.
Characteristics N patients undergoing
transcervical CAS (%)
N patients undergoing
transfemoral CAS (%)
P
Femoral access issues
Severe bilateral aorto-iliac occlusive disease 3 (8) 0 0.03
Abdominal aortic aneurysm (>5 cm) 3 (8) 0 0.03
Aortobifemoral prosthesis 2 (5) 0 0.1
Anatomic issues
Type III aortic arch 8 (18) 6 (7) 0.06
Bovine aortic arch 7 (16) 5 (5.5) 0.06
Common carotid artery tortuosity 11 (25) 11 (12) 0.08
Aortic arch calcifications 10 (23) 9 (10) 0.06
No significant issues 0 60 <0.01
Total 44 91
254 G. Palombo et al.All patients were taking acetylsalicylic acid before the
intervention and had an oral loading dose of clopidogrel
(300 mg) at least 3 h before the procedure. An intravenous
(IV) bolus of heparin (80 IU kg1) was given after sheath
placement. During the procedure, if an activated clotting
time of less than 250 s was found, the patient received an
additional dose of heparin.
Prior to all transcervical procedures, the skin was
marked at the level of the carotid bifurcation under
ultrasound guidance. Then, in the operating room, a needle
was transversally positioned over the skin mark to identify
the carotid bifurcation under fluoroscopic guidance. In all
patients, under local anaesthesia, a small longitudinal
incision, with an estimated length of 2 cm, was made along
the sternocleidomastoid muscle above the clavicle. The
CCA was dissected circumferentially and encircled with
a loop. Then a 6 F  7-cm long introducer sheath (‘Super
Sheath’, Togo Medikit Co., Tokyo, Japan) was inserted
under fluoroscopy over a 0.035-inch guidewire into the CCA,
taking care not to go beyond the bifurcation needle.
Because of its short length, no continuous pressurised
heparinisation of the sheath was deemed necessary. After
confirming ICA stenosis with an angiogram, a cerebral
protection filter (‘Filterwire EZ’, Boston Scientific Corpo-
ration, Mountain View, USA) was placed within the distal
ICA. Predilation of the stenosis with a coronary-artery
balloon was necessary in three patients. Then, a self-
expanding stent (‘Carotid Wallstent Monorail’, Boston
Scientific Corporation, Natick, MA, USA; ‘Precise Carotid
Stent’, Cordis Corporation, Miami, FL, USA) was released at
the carotid bifurcation and post-dilated with a 5- or 6-mm
diameter balloon (‘Ultrasoft SV’, Boston Scientific Corpo-
ration, Natick, MA, USA). Prophylactic intravenous atropine
(1 mg) was routinely administrated before balloon dilation.
A completion angiogram was obtained to confirm satisfac-
tory treatment of the stenosis and the absence of spasm in
the distal ICA. Intra-arterial nitroglycerin (200 mg) was
injected when a spasm occurred. A 6/0 Prolene stitch was
then placed at the arterial puncture site to achieve
haemostasis.
All percutaneous femoral procedures were performed
under local anaesthesia. Common carotid artery cannula-
tion was achieved through a telescopic technique with a 5
or 6 F 90-cm long sheath (‘Flexor Check-Flo Introducer’,Cook, Bloomington, IN, USA), a 5 F diagnostic catheter with
an appropriate shape and a 0.035-inch standard hydrophilic
guidewire (‘Zipwire’, Boston Scientific Corporation, Natick,
MA, USA). Once the long sheath was placed into the
common carotid artery, a pressurised bag of heparinised
saline was connected to its proximal end to prevent
thrombosis. Filter-protected carotid stenting was then
performed as previously described for transcervical proce-
dures. Predilation of the stenosis with a coronary-artery
balloon was necessary in six patients. After femoral sheath
withdrawal, haemostasis was achieved by manual
compression.
MRI sequences were acquired at 1.5 T with a dedicated
brain imaging superconducting magnet. T2-weighted fluid-
attenuation inversion recovery (FLAIR) sequences were
acquired (repetition time (RT): 8000 ms; echo time (ET):
100 ms; inversion time: 2200 ms; field-of-view: 240 mm;
turbo factor: 14; and number of excitations: 2) and DW
sequences were acquired in the three planes at a thickness
of 5 mm (RT 3000, ET 84 ms, b-value 0, 500 and 1000 s
mm2). Patients underwent MRI within 3 days before and
after the procedure. When the MRI scanner was not avail-
able within 3 days or MRI was contraindicated (patients
with pacemakers or suffering claustrophobia), the patient
was excluded from MRI. Two expert neuroradiologists, not
involved in the CAS procedures, compared pre-procedural
and postprocedural images and assessed the presence of
recent ischaemic lesions. Ipsilateral lesions were defined as
those in the operated carotid artery territory and contra-
lateral lesions as those in the non-operated carotid artery
and vertebrobasilar artery territories.
All patients underwent a neurologic examination before
and after the procedure. New neurologic deficits lasting
more than 24 h were defined as a stroke. Qualitative data
were analysed for statistical significance with chi-square
test or Fisher’s exact test as appropriate and quantitative
data with Student’s t-test. P values less than or equal to
0.05 were considered to indicate statistical significance.Results
The procedure was completed in all cases after trans-
cervical CAS. Two transfemoral procedures had to be
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to cannulate the CCA; thus the rate of completed proce-
dures was 97.8%. These patients were excluded from our
study because it was not possible to assign postoperative
ischaemic lesions to either of the procedures. We used
a carotid Wallstent in 114 patients with a straight carotid
artery course whereas the more flexible Precise nitinol
stent was preferred in 21 patients with tortuous carotid
bifurcations. In all cases intraoperative angiography
showed a resolution of the stenosis (residual stenosis
<20%).
During the immediate postoperative course (<30 days),
none of the patients in either group died. We observed five
strokes, all occurring after transfemoral CAS and one
involving the contralateral hemisphere (5/91, 5.5% in the
transfemoral group vs. 0% in the transcervical group,
PZ 0.17, by Fisher’s exact test). In all these patients, an
ischaemic lesion was found at postoperative CT scan (one
patient) or DW-MR (four patients). We also observed 14
transient ischaemic attacks (TIAs), one in the transcervical
group and 13 in the transfemoral group. All patients with
TIA underwent postoperative DW-MR, but in five cases, this
imaging technique did not show any ischaemic lesion. The
difference between the overall rate of neurological events
(TIA and stroke) in the two groups was statistically signifi-
cant (18/91, 19.8% vs. 1/44, 2.3%; P < 0.01, by the chi-
square test). If we exclude the five patients who had
a postoperative TIA after transfemoral CAS but no detect-
able lesion at DW-MR, the difference remains significant
(13/91, 14.3% vs. 1/44, 2.3%; PZ 0.03, by Fisher’s exact
test). One patient, with previously asymptomatic coronary-
artery disease, showed myocardial ischaemic signs after
transfemoral CAS and underwent urgent myocardial revas-
cularisation. No cranial nerve deficits, ICA dissections or
cervical haematomas were observed in transcervical
patients. Similarly, no groin haematomas developed after
transfemoral procedures. A distal ICA spasm developed in
five transfemoral and two transcervical CAS patients but
responded in all cases to intra-arterial nitroglycerine.
Of the 135 patients who underwent filter-protected CAS,
preoperative and postoperative DW-MRI of the brain was
performed in 111 patients (82%) (Table 3). Of these 111
patients, 76 underwent transfemoral CAS (76/91, 83.5%)
and 35 transcervical CAS (35/44, 79.5%). The comparison of
preoperative and postoperative DW-MRI of the brainTable 3 Diffusion-weighted magnetic resonance results in p
stenting.
Patients with postoperative DW-MRI lesions (%)
Patients with at least one contralateral postoperative
DW-MRI lesion (%)
Patients with postoperative DW-MRI lesions
and neurological symptoms (%)
Number of new lesions at DW-MRI
Number of contralateral lesions at DW-MRI (%)
Mean number of lesions per patient (range)
DW-MRI: diffusion-weighted magnetic resonance imaging.disclosed new ischaemic lesions in five patients who
underwent transcervical CAS (5/35, 14.3%) and in 28
patients who underwent transfemoral CAS (28/76, 36.8%),
with a statistically significant difference between the two
groups (PZ 0.015 by the chi-square test). Among these
patients with new DW-MRI ischaemic lesions, postoperative
neurological symptoms were observed in one patient of the
transcervical group and in 12 patients of the transfemoral
group (1/5, 20% vs. 12/28, 43% P > 0.05 by Fischer’s exact
test). In the 76 patients who underwent transfemoral CAS,
26 had an anatomical issue and 50 not. The incidence of
postoperative DW-MRI lesions was significantly higher in the
subgroup with complex anatomy (23/26, 88%) compared
with the subgroup without (5/50, 10%) (P < 0.01, by Fish-
er’s exact test). In the transcervical group, DW-MRI showed
10 new ischaemic lesions, all ipsilateral. In the trans-
femoral group, DW-MRI detected 85 new ischaemic lesions,
66 (78%) ipsilateral and 19 (22%) contralateral (Table 3).
Lesions were located in cortical territories (76 lesions,
80%), subcortical territories (13 lesions, 14%) or deep
territories (six lesions, 6%). No ischaemic lesions were
recorded after CAS done with predilation.Discussion
In these series of patients undergoing filter-protected
carotid stenting through either a percutaneous femoral
approach or a surgical cervical approach, we found a higher
incidence of neurological events (19.8% vs. 2.3%) and
a higher incidence of new DW-MRI ischaemic lesions (36.8%
vs. 14.3%) after transfemoral percutaneous CAS. Based on
our results, transcervical filter-protected CAS seems able to
reduce both symptomatic and asymptomatic cerebral
embolisation occurring during CAS, without carrying a risk
of local complications. We indeed observed no ICA dissec-
tions or relevant cervical haematomas after this procedure.
Even if mini-cervical access does not have a large clinical
application for CAS, the few reports on this matter seem to
confirm the very low incidence of access-related compli-
cations.16,17 Particularly, no cranial nerve injuries were
ever reported after transcervical CAS, thus showing the
considerable difference of this cervical cut-down with the
surgical incision needed for carotid endarterectomy.18
Finally, other authors have reported a low incidence ofatients undergoing transcervical and transfemoral carotid
Transcervical
CAS (nZ 35)
Transfemoral
CAS (nZ 76)
P
5 (14.3) 28 (36.8) 0.015
0 10 (13.1) 0.03
1/5 (20) 12/28 (43) 0.6
10 85
0 19/85 (22) 0.2
2 (1e3) 3.1 (1e8) 0.1
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and haemostasis by a closure device.12 This approach would
undoubtedly reduce the invasiveness and increase the
appeal of this procedure but more data regarding its safety
is needed to allow its more common use.
The results obtained in our series can be ascribed to
instrumentation of the aortic arch which is lacking in the
cervical procedure and is the only procedural difference
between the two groups. Evidence regarding the impact of
this phase on the total embolic load of transfemoral carotid
stenting procedures has been provided by studies using
either transcranial Doppler or DW-MRI. In unselected
patients undergoing transfemoral carotid stenting Al-
Mubarak et al. reported a mean number of 16 microembolic
signals (MESs) during the first phase of the procedure,
namely sheath placement, over a mean number of 68 MESs
recorded during the whole procedure.19 This means that up
to 23% of total procedural embolic load can be related to
aortic arch instrumentation and CCA cannulation. Lower
rates ranging from 10.2% to 11.4%, even though not negli-
gible, can be extrapolated by data reported in other two
transcranial Doppler (TCD) studies.20,21 In an elegant DW-
MRI study, Bendzus et al. documented the occurrence of
new ischaemic lesions in 26% of the patients undergoing
only diagnostic angiography of the supra-aortic trunks.7 A
subgroup analysis of these results also showed an increased
incidence in patients with history of vasculopathy (44%) and
in patients with vessels difficult to probe (53%). Finally, DW-
MRI studies reporting the incidence and the location of
ischaemic lesions after transfemoral protected CAS have
shown the occurrence of ischaemic lesions also in vascular
territories not directly involved by the procedure.4,6 While
some authors have reported even 87% of contralateral
lesions after transfemoral CAS,5 in our experience, the rate
of contralateral lesions stopped at 22%. This is probably due
to the treatment of many patients with complex anatomy
by a cervical access. However, we found a significantly
higher number of patients with contralateral lesions after
transfemoral CAS (13%) than after transcervical CAS (0%).
All these data therefore confirm the considerable impact
of aortic arch instrumentation on the procedural embolic
load.
Current information coming from non-randomised clinical
series argues for the beneficial use of cerebral protection
devices in CAS.22 Several protection devices have been
developed for transfemoral procedures but distal filters are
undoubtedly the most widespread. In the few published
articles on transcervical CAS, good results were reported in
terms of neurological adverse events and postoperative DW-
MRI ischaemic damage using ICA flow reversal as the cerebral
protection system.23,24 This system has the undeniable
advantage of allowing cerebral protection before the first
crossing of the carotid lesion; however, it requires CCA
clamping and entails inter-hemispheric redistribution of
cerebral blood flow. Intolerance to carotid clamping or flow
reversal and relative complexity of arteriovenous fistula
establishment may therefore explain the limited diffusion of
this technique to date. On the other hand, while distal filters
have the advantage of maintaining distal cerebral perfusion
during the whole procedure, they do not provide protection
during the first crossing of ICA stenosis. Nevertheless, the
positive clinical results previously reported by Alexandrescuet al. after filter-protected transcervical CAS seem to be
confirmed in our series.13 The technique used by Alexan-
drescu et al. also included transitory blood aspiration during
first crossing of ICA stenosis to reduce embolic risk and
yielded zero adverse neurological events in a group of 26
patients. Since patients with very tight stenoses, in whom
crossing of the lesion may be difficult and risky, were
excluded from this study and referred to surgery, we found
this additional manoeuvre unnecessary and thus did not use
it in any patient. However, we can speculate that blood
aspiration or carotid clamping, in patients tolerating such
manoeuvres, could have further decreased our low incidence
of DW-MRI ischaemic lesions.
This study has some limitations that should be
acknowledged. First of all, it is a non-randomised obser-
vational study including a relatively small number of
patients. Second, we used DW-MR to compare the silent
brain damage occurring after two different techniques but
the real clinical impact of postoperative DW-MR lesions has
yet to be clarified. This tool has nevertheless the advantage
to allow an objective comparison between two techniques.
In conclusion, in this non-randomised single-centre study
comparing surgical cervical access to percutaneous femoral
access for CAS, we found cervical access to reduce the
inherent cerebral embolisation of transfemoral carotid
stenting. Even if an optimal cerebral protection system
during transcervical CAS is still controversial, distal filters
seem able to provide effective cerebral protection in
selected patients. In our opinion, not all CAS procedures
should be done by a cervical access but all intervention-
alists should acquire and be able to use this technique
selectively, not only to overcome possible difficulties linked
to femoral access but also to reduce adverse events in
patients with complex anatomy.
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